Matches in Nanopublications for { ?s ?p "[We hypothesized that: 1) CD1 expression increases with disease progression to advanced SCC, and 2) AS-cyclin D1 therapy would lead to prolonged tumor regression in a xenograft model of human SCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP878075.RAlULukM6vsWfKYh4a95HC9jX9jbbkjk-T-NAN-wLMNcY130_assertion description "[We hypothesized that: 1) CD1 expression increases with disease progression to advanced SCC, and 2) AS-cyclin D1 therapy would lead to prolonged tumor regression in a xenograft model of human SCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878075.RAlULukM6vsWfKYh4a95HC9jX9jbbkjk-T-NAN-wLMNcY130_provenance.
- NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_assertion description "[We hypothesized that: 1) CD1 expression increases with disease progression to advanced SCC, and 2) AS-cyclin D1 therapy would lead to prolonged tumor regression in a xenograft model of human SCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_provenance.
- NP740206.RAgfHDjVl9vqjFYOSbLQy0qCM3bHnUp9ZcrO1gl1ldWIM130_assertion description "[We hypothesized that: 1) CD1 expression increases with disease progression to advanced SCC, and 2) AS-cyclin D1 therapy would lead to prolonged tumor regression in a xenograft model of human SCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740206.RAgfHDjVl9vqjFYOSbLQy0qCM3bHnUp9ZcrO1gl1ldWIM130_provenance.
- NP602420.RAzdQYAfYsVCPeXGuU8t3DeqDibr1z0pYZT845W5pk8u0130_assertion description "[We hypothesized that: 1) CD1 expression increases with disease progression to advanced SCC, and 2) AS-cyclin D1 therapy would lead to prolonged tumor regression in a xenograft model of human SCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602420.RAzdQYAfYsVCPeXGuU8t3DeqDibr1z0pYZT845W5pk8u0130_provenance.
- NP736605.RAn1_U8FtIJO0cxp_b1LRGyYRkrfQiF-uAfiPTJyRF4Uo130_assertion description "[We hypothesized that: 1) CD1 expression increases with disease progression to advanced SCC, and 2) AS-cyclin D1 therapy would lead to prolonged tumor regression in a xenograft model of human SCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736605.RAn1_U8FtIJO0cxp_b1LRGyYRkrfQiF-uAfiPTJyRF4Uo130_provenance.
- NP252872.RALwg6g0RK2XkZUgRIHSRfz-PXECowp2vPR1histVM7HI130_assertion description "[We hypothesized that: 1) CD1 expression increases with disease progression to advanced SCC, and 2) AS-cyclin D1 therapy would lead to prolonged tumor regression in a xenograft model of human SCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252872.RALwg6g0RK2XkZUgRIHSRfz-PXECowp2vPR1histVM7HI130_provenance.
- NP232958.RA_-XOgICHI284YOC11b4Js6DR8S29MggMhBL_AdzcqkQ130_assertion description "[We hypothesized that: 1) CD1 expression increases with disease progression to advanced SCC, and 2) AS-cyclin D1 therapy would lead to prolonged tumor regression in a xenograft model of human SCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232958.RA_-XOgICHI284YOC11b4Js6DR8S29MggMhBL_AdzcqkQ130_provenance.
- NP628836.RA8bX5-p-qUWm6gHZCvXTLaKN-WeBuIlqS-3HdDRxk1qc130_assertion description "[We hypothesized that: 1) CD1 expression increases with disease progression to advanced SCC, and 2) AS-cyclin D1 therapy would lead to prolonged tumor regression in a xenograft model of human SCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628836.RA8bX5-p-qUWm6gHZCvXTLaKN-WeBuIlqS-3HdDRxk1qc130_provenance.